3859620_MotusGi+Logo2.jpg
Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation
June 16, 2021 08:00 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., June 16, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
3859620_MotusGi+Logo2.jpg
Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
June 03, 2021 08:00 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
3859620_MotusGi+Logo2.jpg
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
May 25, 2021 08:05 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., May 25, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve...
3859620_MotusGi+Logo2.jpg
Motus GI Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 16:05 ET | Motus GI Holdings, Inc.
Received 510(k) clearance from FDA for Pure-Vu disposable sleeve for Upper GI endoscopiesRevenue growth of ~40% compared to prior quarterAdditional prominent U.S. medical centers signed to committed...
3859620_MotusGi+Logo2.jpg
Motus GI Announces Publication of a Pure-Vu System® Cost Effectiveness Analysis in the Journal of Cost Effectiveness and Resource Allocation
May 07, 2021 07:30 ET | Motus GI Holdings, Inc.
- - -- The article states Pure-Vu System is estimated to provide lifetime saving of $833- $992 per patient when compared to standard of care for outpatient colorectal cancer (CRC) screening and...
3859620_MotusGi+Logo2.jpg
Motus GI Receives FDA Clearance to Market the Pure-Vu® System for Upper GI Endoscopy
April 30, 2021 07:30 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
3859620_MotusGi+Logo2.jpg
Motus GI to Release First Quarter Results and Provide a Business Update on May 13
April 29, 2021 16:01 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
3859620_MotusGi+Logo2.jpg
Motus GI Submits 510(k) Application to FDA for the Pure-Vu System for Upper GI Endoscopy
April 06, 2021 08:00 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., April 06, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
3859620_MotusGi+Logo2.jpg
Motus GI Reports Fourth Quarter 2020 Financial Results and Provides Corporate Update
March 16, 2021 16:05 ET | Motus GI Holdings, Inc.
Signed new 12-month committed volume contracts with two prominent U.S. medical centersReported progress on reimbursement for Pure-Vu System in both inpatient and outpatient markets, starting with CMS...
3859620_MotusGi+Logo2.jpg
Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center
March 15, 2021 16:05 ET | Motus GI Holdings, Inc.
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...